Evidence mapPaperPMID 42003870Full record

ArticleInternational journal of cardiology. Cardiovascular risk and prevention2026

Relation between albuminuria levels and the incidence of cardiovascular events in adult population in Northern Mexico: A 5-year follow-up survival analysis.

Miguel Eduardo Garcia-Castillo, Dalia Gutierrez-González, Ana Sofía Sánchez-García, Iván Francisco Fernández-Chau, Christian Reguera-Hernández, Andrea Vallejo, María Fernanda Garcés-Pérez, Carlos Alejandro Molina-Guajardo, Arnulfo Gonzalez-Cantu, Maria Elena RomeroIbarguengoitia

Abstract read
In one paragraph

Article in International journal of cardiology. Cardiovascular risk and prevention, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miguel Eduardo Garcia-CastilloTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Dalia Gutierrez-GonzálezTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Ana Sofía Sánchez-GarcíaTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Iván Francisco Fernández-ChauTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Christian Reguera-HernándezTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Andrea VallejoTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
María Fernanda Garcés-PérezInternal Medicine Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Carlos Alejandro Molina-GuajardoNephrology and Hemodialysis Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Arnulfo Gonzalez-CantuTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.
Maria Elena RomeroIbarguengoitiaTeaching and Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de Los Garza, Nuevo León, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Albuminuria has emerged as a key marker for cardiovascular (CV) and renal risk. Despite its clinical relevance, its role as a continuous and stratified predictor of ischemic CV events remains underexplored in Latin American populations, further evidence is needed to assess the prognostic value of urinary albumin-creatinine ratio (UACR) in this context. Methods: A retrospective cohort of Mexican adults with UACR measured in 2019 and 5-year follow-up was conducted. UACR levels were classified per 2024 CKD Prognosis Consortium and KDIGO guidelines. Cox model regressions were used to analyze CV events-including myocardial infarction, ischemic stroke, heart failure, unstable angina, and transient ischemic attack -along with overall mortality and associated variables. Results: Among 809 patients [mean (SD) age 55 Conclusions: Higher levels of UACR, starting from A1 category, were independently associated with increased risk of CV events and mortality. These findings support the use of UACR as a continuous and stratified marker for CV and renal risk in high-risk populations, even beyond the context of diabetes.

Identifiers

PMID42003870
PMCPMC13091358

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.